• Q-VD(OMe)-OPh for Cell-Death Attribution in CRC

  2026-09-23

  Learn how Q-VD(OMe)-OPh can help test whether apoptosis contributes to drug responses in cetuximab-resistant colorectal cancer models. This article interprets a study of 3-bromopyruvate plus cetuximab through the practical lens of distinguishing caspase-dependent apoptosis from ferroptosis and autophagy.

• Cap-Independent Translation of Linear mRNA

  2026-09-23

  The reference study introduces an azide-functionalized dinucleotide priming and click-chemistry workflow for improving cap-independent translation of linear mRNA. Its findings indicate that engineered 5′-end chemistry can increase transcript stability and protein output while providing a practical way to study cellular transfection and translation without relying on a conventional 5′ cap.

• JNJ-10198409: PDGF Receptor Inhibition

  2026-09-22

  JNJ-10198409 is a platelet-derived growth factor receptor inhibitor that competitively targets the ATP-binding site of the PDGF-BB receptor. Its reported in vitro IC50 is 4.2 nM in human coronary artery smooth muscle cells, making it a useful starting point for tumor growth, angiogenesis, and fibrotic disorder research.

• From Root Canal Disinfection to Viability Insight

  2026-09-22

  A translational perspective on how Calcein AM/PI fluorescence can connect antimicrobial performance with mammalian host-cell safety in cerium oxide nanoparticle research, while clarifying assay boundaries, workflow design, and evidence expectations.

• CCR7–Notch1 Crosstalk Sustains Mammary Cancer Stemness

  2026-09-21

  Boyle et al. showed that CCR7 and Notch1 signaling functionally intersect to maintain stem-like properties in primary MMTV-PyMT mammary cancer cells. The study provides a mechanistic basis for investigating coordinated pathway inhibition, while its mouse-model design also defines important limits for translation to human breast cancer.

• Cyanidin Chloride: Evidence and Research Workflow

  2026-09-21

  Cyanidin Chloride is an anthocyanin polyphenolic antioxidant listed as product N2525 with a molecular weight of 322.7 g/mol and approximately 98–99% purity. Its documented solubility and storage parameters support controlled oxidative stress research, while published skin-model findings require careful separation of Cyanidin Chloride from the differently named glycoside cyanin chloride.

• (R,S)-Anatabine Workflows for Aβ Research

  2026-09-20

  (R,S)-Anatabine supports a mechanism-led Alzheimer’s workflow that connects soluble Aβ peptide reduction with APP processing, BACE-1 expression, and NF-κB signaling. This guide shows how to move from SH-SY5Y screening to an in vivo Alzheimer’s disease model while controlling solvent, timing, readout, and interpretation risks.

• Bestatin, CD13, and Endothelial Invasion in Fibrin

  2026-09-19

  The 2003 reference study showed that bestatin, despite reported anti-angiogenic activity in other models, dose-dependently enhanced microvascular endothelial capillary-like tube formation in a fibrin matrix. Its findings redirect mechanistic attention from CD13 alone toward additional cell-surface aminopeptidases and highlight how matrix context can alter the apparent effect of a protease inhibitor.

• HyperTrap Heparin HP Column for Assay Design

  2026-09-18

  The HyperTrap Heparin HP Column supports a decision-oriented workflow for enriching signaling proteins, growth factors, and nucleic acid enzymes. This article connects its heparin-affinity chemistry with practical assay design for investigating CCR7–Notch1-regulated cancer stemness without overstating what purification alone can prove.

• Linoleic Acid: Assays, Workflows, and Troubleshooting

  2026-09-18

  Linoleic Acid (C18:2(9Z,12Z)) provides a defined lipid input for oxidative stress, membrane, erythrocyte, epithelial migration, and essential fatty acid studies. This practical guide connects controlled reagent handling with the AMPK–MNK–eIF4E signaling concept reported in a recent Nature study, while separating established applications from testable extensions.

• 2X Taq PCR Master Mix for CAdV-2 Genotyping

  2026-09-17

  Build a practical CAdV-2 genotyping workflow around direct gel loading, deletion-aware primer design, and TA-cloning compatibility. This guide shows how to use a ready-to-use mix for rapid screening while avoiding common interpretation errors around small E3 deletions and pathogenicity.

• N4-Acetylcytidine Workflows for ac4C Research

  2026-09-17

  N4-Acetylcytidine enables controlled studies of free ac4C nucleoside metabolism, enzyme specificity, and RNA modification biology. This workflow-focused guide explains how to separate nucleotide-processing activity from direct RNA deacetylation while improving solubility, storage, assay design, and troubleshooting.

• Bestatin, CD13, and Endothelial Invasion in Fibrin

  2026-09-16

  The 2003 study by van Hensbergen and colleagues challenged the assumption that bestatin is uniformly anti-angiogenic by showing that it dose-dependently enhanced microvascular endothelial tube formation in a fibrin matrix. Its results emphasize that aminopeptidase inhibition can produce matrix- and concentration-dependent effects, with important implications for interpreting bestatin and CD13 as therapeutic targets.

• Moesin as a Biomarker of Endothelial Injury in Sepsis

  2026-09-16

  The reference study identifies circulating moesin as a candidate biomarker of endothelial injury and sepsis severity, linking serum levels with SOFA scores, procalcitonin, and experimental lung damage. Its integrated patient, animal, and endothelial-cell models also suggest that moesin participates in Rock1/MLC and NF-κB signaling that promotes vascular hyperpermeability.

• Deferasirox Review: Oral Iron Chelation Evidence

  2026-09-15

  The reference formulary review positioned deferasirox as an oral, tridentate Fe3+-selective chelator that could reduce the adherence burden associated with parenteral deferoxamine. Its most meaningful evidence was noninferiority in patients with higher hepatic iron burdens, combined with strong patient preference for the oral regimen, while cardiac iron mobilization and long-term safety remained important limitations.

7810 records 1/521 page Next 12345 下5页 Last page